RecruitingEarly Phase 1NCT05753813

Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome

Sponsor

Queen's Medical Center

Enrollment

22 participants

Start Date

Dec 15, 2023

Study Type

INTERVENTIONAL

Conditions

Vulvovaginal candidiasis Bacterial vaginosis

Summary

This project aims to investigate if the contraceptive method, Phexxi, causes changes to the composition of the vaginal microbiome. The investigators hypothesize that regular use of Phexxi will cause increased colonization of lactic acid-producing lactobacilli, which could have positive effects in the way of preventing recurrent episodes of BV and candida infections.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 54 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Phexxi for people with bacterial vaginosis and vulvovaginal candidiasis. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 54 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.